Published in J Hepatol on September 01, 1999
RCT of Stent Versus Standard Therapy in Oesophageal Variceal Haemorrhage (SOV) | NCT01851564
Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhage. Dig Dis Sci (2008) 0.95
Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding. Dig Dis Sci (2001) 0.94
Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis. World J Surg (2009) 0.93
Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr (2013) 0.93
Predictors of early rebleeding and mortality after acute variceal hemorrhage in patients with cirrhosis. Nat Clin Pract Gastroenterol Hepatol (2008) 0.92
The first Egyptian experience using new self-expandable metal stents in acute esophageal variceal bleeding: pilot study. Saudi J Gastroenterol (2013) 0.91
Management of portal hypertension. Postgrad Med J (2004) 0.90
Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol (2010) 0.87
Application of endoscopy in improving survival of cirrhotic patients with acute variceal hemorrhage. Int J Hepatol (2011) 0.84
Endoscopic management of esophageal varices. World J Gastrointest Endosc (2012) 0.81
Acute variceal bleeding: general management. World J Gastroenterol (2001) 0.81
Risk factors of early re-bleeding and mortality in patients with ruptured gastric varices and concomitant hepatocellular carcinoma. J Gastroenterol (2012) 0.78
Liver: Early TIPS in patients with cirrhosis and variceal bleeding. Nat Rev Gastroenterol Hepatol (2010) 0.76
Endoscopic management of portal hypertension. Int J Hepatol (2012) 0.76
Nanocomplexation of thrombin with cationic amylose derivative for improved stability and hemostatic efficacy. Int J Nanomedicine (2015) 0.76
Esophageal Stent for Refractory Variceal Bleeding: A Systemic Review and Meta-Analysis. Biomed Res Int (2016) 0.75
Predictive factors for failure to control bleeding in cirrhotic patients. J Hepatol (2000) 0.75
Role of self-expanding metal stents in the management of variceal haemorrhage: Hype or hope? World J Gastrointest Endosc (2016) 0.75
Addition of Somatostatin After Successful Endoscopic Variceal Ligation Does not Prevent Early Rebleeding in Comparison to Placebo: A Double Blind Randomized Controlled Trial. J Clin Exp Hepatol (2015) 0.75
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Alcohol and mortality in British men: explaining the U-shaped curve. Lancet (1988) 5.34
Carcinoid tumour. Lancet (1998) 4.52
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther (2014) 3.98
Physical activity and ischaemic heart disease in middle-aged British men. Br Heart J (1991) 3.81
Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke (1999) 2.89
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev (2007) 2.75
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol (2010) 2.50
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Bacterial infection in the pathogenesis of variceal bleeding. Lancet (1999) 2.35
Height and social class in middle-aged British men. J Epidemiol Community Health (1988) 2.34
The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant (2012) 2.29
Coagulation and fibrosis in chronic liver disease. Gut (2008) 2.22
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy (2006) 2.22
Systematic review and meta-analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg (2011) 2.13
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther (2006) 2.00
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet (1999) 1.98
"Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology (1998) 1.95
Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol (2002) 1.92
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology (2002) 1.90
Marital status, change in marital status, and mortality in middle-aged British men. Am J Epidemiol (1995) 1.89
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther (2005) 1.86
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78
Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet (2000) 1.75
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med (1992) 1.72
Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut (1998) 1.63
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev (2006) 1.63
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost (2010) 1.62
Alcohol and coronary heart disease: a perspective from the British Regional Heart Study. Int J Epidemiol (1994) 1.62
Milk, butter, and heart disease. BMJ (1991) 1.62
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol (1999) 1.60
Review article: portal vein thrombosis -- new insights into aetiology and management. Aliment Pharmacol Ther (2005) 1.59
Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology (1998) 1.57
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study. Aliment Pharmacol Ther (2013) 1.56
What role for statins? A review and economic model. Health Technol Assess (1999) 1.53
Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil. Am J Transplant (2009) 1.52
Diurnal pattern of variceal bleeding in cirrhotic patients. J Hepatol (1993) 1.47
Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. Am J Transplant (2006) 1.47
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther (2011) 1.46
Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J (1993) 1.46
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long. Am J Transplant (2013) 1.40
Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients. Br J Radiol (2004) 1.40
Infection, coagulation, and variceal bleeding in cirrhosis. Gut (2005) 1.39
Staple-line erosion: a common source of recurrent bleeding following stapled oesophageal transection. Br J Surg (1991) 1.39
Ultrasound screening for hepatocellular carcinoma (HCC) in cirrhosis: the evidence for an established clinical practice. Clin Radiol (1998) 1.38
Alcohol and blood pressure in middle-aged British men. J Hum Hypertens (1988) 1.38
Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem (1995) 1.38
LeVeen shunt with wandering tip. Lancet (1991) 1.36
Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med (1982) 1.36
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2004) 1.35
Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther (2009) 1.35
Controversies in the management of bleeding esophageal varices (1) N Engl J Med (1989) 1.30
Observer bias in blood pressure studies. J Hypertens (1988) 1.29
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology (1999) 1.29
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol (1992) 1.27
Changes in drinking habits in middle-aged British men. J R Coll Gen Pract (1988) 1.26
Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias. Am J Transplant (2007) 1.25
Endoscopic extraction of bile duct stones: management related to stone size. Gut (1993) 1.24
Bacteriuria and primary biliary cirrhosis. Gut (1984) 1.20
Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am J Transplant (2012) 1.19
Donor-specific bone marrow infusion after orthotopic liver transplantation. Lancet (1994) 1.18
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma. Br J Cancer (2013) 1.17
Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics. Aliment Pharmacol Ther (2006) 1.17
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther (2006) 1.15
Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes. Liver Transpl (2001) 1.15
Should we biopsy each liver mass suspicious for HCC before liver transplantation?--no, please don't. J Hepatol (2005) 1.15
Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol (1992) 1.14
Controversies in the management of bleeding esophageal varices (2) N Engl J Med (1989) 1.14
Treatment of small hepatocellular carcinomas. Lancet (1992) 1.13
In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver (1997) 1.13
Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology (1995) 1.11
Bleeding time in patients with hepatic cirrhosis. BMJ (1990) 1.10
Hepatocellular ballooning after liver transplantation: a light and electronmicroscopic study with clinicopathological correlation. Histopathology (1991) 1.10
Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia. Hum Pathol (1991) 1.10
Why portal hypertensive varices bleed and bleed: a hypothesis. Gut (1995) 1.10
Molecular mimicry in liver disease. Nature (1992) 1.10
Disopyramide and warfarin interaction. Br Med J (1977) 1.09
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol (1998) 1.09
Reducing early exposure to calcineurin inhibitors: the key factor for a successful renal sparing strategy. Am J Transplant (2012) 1.09
A critical threshold of exercise capacity in the ventilatory response to exercise in heart failure. Br Heart J (1991) 1.08
Long-standing asymptomatic primary sclerosing cholangitis: report of three cases. Dig Dis Sci (1981) 1.08
M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol (1993) 1.07
Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol (1998) 1.07
Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther (2006) 1.06
Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992. J Hepatol (1994) 1.05
A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer. Ann Oncol (2013) 1.04
Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol (1999) 1.04
Follow-up in gastric dysplasia patients. Am J Surg Pathol (1989) 1.03
Desmopressin and bleeding time in patients with cirrhosis. Br Med J (Clin Res Ed) (1985) 1.03
Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg (1994) 1.02
Physical activity, hypertension and risk of heart attack in men without evidence of ischaemic heart disease. J Hum Hypertens (1994) 1.01
A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol (1993) 1.00
Analysis of intrapulmonary right to left shunt in the hepatopulmonary syndrome. J Hepatol (1998) 0.99